Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
28
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Koziel Margaret | Chief Medical Officer | 7 | $0 | $4.0K | 2023-03-01 |
| Fehlner Paul | SVP and Chief Legal Officer | 8 | $20.0K | $3.4K | 2023-02-17 |
| Hinshaw William | President and CEO | 13 | $25.0K | $52.3K | 2023-02-17 |
| NISSEN TORBEN STRAIGHT | Director | 1 | $0 | $0 | 2022-11-16 |
| Rosiello Robert L. | Director | 1 | $0 | $0 | 2022-11-16 |
| Societe des Produits Nestle S.A. | 10% Owner | 3 | $12.00M | $0 | 2022-10-13 |
| Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | 34 | $57.15M | $0 | 2022-10-13 |
| Hendrix Martin | Director | 1 | $0 | $0 | 2022-05-19 |
| Rondinone CRISTINA | Director | 4 | $0 | $0 | 2022-05-19 |
| Pisano Gary P. | Director | 6 | $0 | $0 | 2022-05-19 |
| Sohn Catherine A. | Director | 5 | $4.9K | $0 | 2022-05-19 |
| Baird William D III | Director | 4 | $0 | $0 | 2022-05-19 |
| Rosenblatt Michael | Director | 1 | $0 | $0 | 2022-05-19 |
| Epstein David R | Director | 54 | $786.7K | $0 | 2022-05-19 |
| SEKHRI PAUL J | Director | 1 | $0 | $0 | 2022-05-19 |
| Crane Robert | Chief Financial Officer | 2 | $75.0K | $0 | 2022-03-16 |
| Dean Virginia R | SVP, Chief People Officer | 2 | $0 | $0 | 2022-02-08 |
| Schecter Alison D. | President - Research & Dev. | 3 | $0 | $0 | 2022-02-08 |
| Aradhye Shreeram | EVP & Chief Developmnt Officer | 4 | $0 | $0 | 2021-05-20 |
| Hoge Stephen | Director | 3 | $0 | $0 | 2021-05-20 |
| Behar Gregory | Director | 3 | $0 | $0 | 2021-05-20 |
| Chakravarthy Manu | SVP & Chief Medical Officer | 6 | $0 | $101.6K | 2021-02-09 |
| Chardonnet Laurent | Chief Financial Officer | 8 | $18.1K | $0 | 2021-02-09 |
| NIMCO US, Inc. | 10% Owner | 1 | $9.20M | $0 | 2020-05-18 |
| King-Jones Heidy | General Counsel, SVP Legal | 1 | $0 | $0 | 2019-12-18 |
| Mitchener Stephen | SVP & Chief Business Officer | 1 | $0 | $0 | 2019-12-18 |
| Tramontin Tony | SVP & Chief Scientific Officer | 1 | $0 | $0 | 2019-12-18 |
| BERRY DAVID A | Director | 1 | $0 | $0 | 2019-05-22 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Koziel Margaret | Chief Medical Officer | S Sale | 2023-03-01 | 2023-03-03 | 679 | $0.58 | $394 | 24,883 | SEC↗ |
| Fehlner Paul | SVP & Chief Legal Officer | A Award deriv | 2023-02-17 | 2023-02-24 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Hinshaw William | President & CEO | A Award deriv | 2023-02-17 | 2023-02-24 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Koziel Margaret | Chief Medical Officer | A Award deriv | 2023-02-17 | 2023-02-24 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Fehlner Paul | SVP & Chief Legal Officer | S Sale | 2023-02-10 | 2023-02-13 | 5,221 | $0.66 | $3.4K | 58,081 | SEC↗ |
| Rosiello Robert L. | Director | A Award deriv | 2022-11-16 | 2022-11-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NISSEN TORBEN STRAIGHT | Director | A Award deriv | 2022-11-16 | 2022-11-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Hinshaw William | President & CEO | S Sale | 2022-10-19 | 2022-10-19 | 16,000 | $1.56 | $25.0K | 82,012 | SEC↗ |
| Hinshaw William | President & CEO | A Award | 2022-10-17 | 2022-10-19 | 50,000 | — | $0 | 98,012 | SEC↗ |
| Societe des Produits Nestle S. | 10% Owner | P Buy | 2022-10-13 | 2022-10-17 | 3,658,536 | $1.64 | $6.00M | 11,105,438 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2022-10-13 | 2022-10-17 | 914,634 | $1.64 | $1.50M | 5,380,500 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2022-10-13 | 2022-10-17 | 2,743,902 | $1.64 | $4.50M | 11,344,305 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2022-10-13 | 2022-10-17 | 2,757,333 | $1.64 | $4.52M | 14,101,638 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2022-10-13 | 2022-10-17 | 919,111 | $1.64 | $1.51M | 6,299,611 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2022-10-13 | 2022-10-17 | 3,048,780 | $1.64 | $5.00M | 3,048,780 | SEC↗ |
| Koziel Margaret | Chief Medical Officer | S Sale | 2022-09-06 | 2022-09-08 | 547 | $2.52 | $1.4K | 25,562 | SEC↗ |
| Koziel Margaret | Chief Medical Officer | S Sale | 2022-06-01 | 2022-06-02 | 590 | $2.01 | $1.2K | 26,109 | SEC↗ |
| Rosenblatt Michael | Director | A Award deriv | 2022-05-19 | 2022-05-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Pisano Gary P. | Director | A Award deriv | 2022-05-19 | 2022-05-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Rondinone CRISTINA | Director | A Award deriv | 2022-05-19 | 2022-05-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Baird William D III | Director | A Award deriv | 2022-05-19 | 2022-05-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2022-05-19 | 2022-05-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hendrix Martin | Director | A Award deriv | 2022-05-19 | 2022-05-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SEKHRI PAUL J | Director | A Award deriv | 2022-05-19 | 2022-05-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Epstein David R | Director | A Award | 2022-05-19 | 2022-06-03 | 47,059 | — | $0 | 209,756 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2022-03-18 | 2022-03-21 | 1,535 | — | $0 | 0 | SEC↗ |
| Epstein David R | Director | M Exercise | 2022-03-18 | 2022-03-21 | 1,535 | — | $0 | 162,697 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2022-03-17 | 2022-03-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Crane Robert | Chief Financial Officer | A Award deriv | 2022-03-16 | 2022-03-18 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Societe des Produits Nestle S. | 10% Owner | P Buy | 2022-03-16 | 2022-03-16 | 3,141,361 | $1.91 | $6.00M | 7,446,902 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2022-03-16 | 2022-03-18 | 947,905 | $1.91 | $1.81M | 2,004,657 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2022-03-16 | 2022-03-18 | 3,791,623 | $1.91 | $7.24M | 8,600,403 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2022-03-16 | 2022-03-18 | 1,579,843 | $1.91 | $3.02M | 4,465,866 | SEC↗ |
| Crane Robert | Chief Financial Officer | P Buy | 2022-03-16 | 2022-03-18 | 39,267 | $1.91 | $75.0K | 39,267 | SEC↗ |
| Epstein David R | Director | P Buy | 2022-03-16 | 2022-03-18 | 26,178 | $1.91 | $50.0K | 161,162 | SEC↗ |
| Fehlner Paul | SVP & Chief Legal Officer | P Buy | 2022-03-16 | 2022-03-18 | 10,471 | $1.91 | $20.0K | 20,802 | SEC↗ |
| Hinshaw William | President & CEO | P Buy | 2022-03-16 | 2022-03-18 | 13,089 | $1.91 | $25.0K | 48,012 | SEC↗ |
| Koziel Margaret | Chief Medical Officer | S Sale | 2022-03-01 | 2022-03-03 | 553 | $1.86 | $1.0K | 26,699 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2022-02-18 | 2022-02-23 | 1,534 | — | $0 | 1,535 | SEC↗ |
| Epstein David R | Director | M Exercise | 2022-02-18 | 2022-02-23 | 1,534 | — | $0 | 134,984 | SEC↗ |
| Dean Virginia R | SVP, Chief People Officer | A Award deriv | 2022-02-08 | 2022-02-10 | 71,400 | — | $0 | 71,400 | SEC↗ |
| Koziel Margaret | Chief Medical Officer | A Award deriv | 2022-02-08 | 2022-02-10 | 33,397 | — | $0 | 33,397 | SEC↗ |
| Hinshaw William | President & CEO | A Award deriv | 2022-02-08 | 2022-02-10 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Hinshaw William | President & CEO | A Award deriv | 2022-02-08 | 2022-02-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Fehlner Paul | SVP & Chief Legal Officer | A Award deriv | 2022-02-08 | 2022-02-10 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Schecter Alison D. | President - Research & Dev. | A Award deriv | 2022-02-08 | 2022-02-10 | 56,000 | — | $0 | 56,000 | SEC↗ |
| Hinshaw William | President and CEO | S Sale | 2022-01-31 | 2022-02-01 | 16,590 | $1.65 | $27.4K | 33,410 | SEC↗ |
| Hinshaw William | President and CEO | M Exercise deriv | 2022-01-28 | 2022-02-01 | 50,000 | — | $0 | 0 | SEC↗ |
| Hinshaw William | President and CEO | M Exercise | 2022-01-28 | 2022-02-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2022-01-18 | 2022-01-20 | 1,535 | — | $0 | 3,069 | SEC↗ |
| Epstein David R | Director | M Exercise | 2022-01-18 | 2022-01-20 | 1,535 | — | $0 | 133,450 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2021-12-17 | 2021-12-20 | 1,535 | — | $0 | 4,604 | SEC↗ |
| Epstein David R | Director | M Exercise | 2021-12-17 | 2021-12-20 | 1,535 | — | $0 | 131,915 | SEC↗ |
| Koziel Margaret | Chief Medical Officer | A Award deriv | 2021-12-10 | 2021-12-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| President - Research & Dev. | A Award deriv | 2021-12-10 | 2021-12-14 | 25,000 | — | $0 | 25,000 | SEC↗ | |
| Epstein David R | Director | M Exercise deriv | 2021-11-18 | 2021-11-22 | 1,534 | — | $0 | 6,139 | SEC↗ |
| Epstein David R | Director | M Exercise | 2021-11-18 | 2021-11-22 | 1,534 | — | $0 | 130,380 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2021-10-18 | 2021-10-19 | 1,535 | — | $0 | 7,673 | SEC↗ |
| Epstein David R | Director | M Exercise | 2021-10-18 | 2021-10-19 | 1,535 | — | $0 | 128,846 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2021-09-17 | 2021-09-20 | 1,535 | — | $0 | 9,208 | SEC↗ |
| Epstein David R | Director | M Exercise | 2021-09-17 | 2021-09-20 | 1,535 | — | $0 | 127,311 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2021-08-18 | 2021-08-19 | 1,534 | — | $0 | 10,743 | SEC↗ |
| Epstein David R | Director | M Exercise | 2021-08-18 | 2021-08-19 | 1,534 | — | $0 | 125,776 | SEC↗ |
| Pisano Gary P. | Director | M Exercise deriv | 2021-08-13 | 2021-08-25 | 81,433 | — | $0 | 0 | SEC↗ |
| Pisano Gary P. | Director | M Exercise | 2021-08-13 | 2021-08-25 | 81,433 | $0.28 | $22.8K | 81,433 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2021-07-16 | 2021-07-20 | 1,535 | — | $0 | 12,277 | SEC↗ |
| Epstein David R | Director | M Exercise | 2021-07-16 | 2021-07-20 | 1,535 | — | $0 | 124,242 | SEC↗ |
| Dean Virginia R | SVP, Chief People Officer | A Award deriv | 2021-06-22 | 2021-06-25 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2021-06-18 | 2021-06-21 | 1,535 | — | $0 | 13,812 | SEC↗ |
| Epstein David R | Director | M Exercise | 2021-06-18 | 2021-06-21 | 1,535 | — | $0 | 122,707 | SEC↗ |
| Aradhye Shreeram | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Baird William D III | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Behar Gregory | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hoge Stephen | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Pisano Gary P. | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Rondinone CRISTINA | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2021-05-18 | 2021-05-20 | 1,534 | — | $0 | 15,347 | SEC↗ |
| Epstein David R | Director | M Exercise | 2021-05-18 | 2021-05-20 | 1,534 | — | $0 | 121,172 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2021-04-18 | 2021-04-20 | 1,535 | — | $0 | 16,881 | SEC↗ |
| Epstein David R | Director | M Exercise | 2021-04-18 | 2021-04-20 | 1,535 | — | $0 | 119,638 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2021-03-18 | 2021-03-22 | 18,416 | — | $0 | 18,416 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2021-03-18 | 2021-03-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Schecter Alison D. | President - Research & Dev. | A Award deriv | 2021-03-17 | 2021-03-18 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Chakravarthy Manu | SVP & Chief Medical Officer | A Award deriv | 2021-02-09 | 2021-02-11 | 102,000 | — | $0 | 102,000 | SEC↗ |
| Hinshaw William | President and CEO | A Award deriv | 2021-02-09 | 2021-02-11 | 375,000 | — | $0 | 375,000 | SEC↗ |
| Fehlner Paul | SVP and Chief Legal Officer | A Award deriv | 2021-02-09 | 2021-02-11 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Fehlner Paul | SVP and Chief Legal Officer | A Award deriv | 2021-02-09 | 2021-02-11 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Chardonnet Laurent | Chief Financial Officer | A Award deriv | 2021-02-09 | 2021-02-11 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Chardonnet Laurent | Chief Financial Officer | A Award deriv | 2021-02-09 | 2021-02-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Chardonnet Laurent | Chief Financial Officer | A Award deriv | 2021-02-09 | 2021-02-11 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Chakravarthy Manu | SVP & Chief Medical Officer | M Exercise deriv | 2021-02-01 | 2021-02-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Chakravarthy Manu | SVP & Chief Medical Officer | S Sale | 2021-02-01 | 2021-02-03 | 18,472 | $5.50 | $101.6K | 41,528 | SEC↗ |
| Chakravarthy Manu | SVP & Chief Medical Officer | M Exercise | 2021-02-01 | 2021-02-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Chardonnet Laurent | Chief Financial Officer | A Award | 2020-10-30 | 2021-02-11 | 2,601 | $3.60 | $9.4K | 6,266 | SEC↗ |
| Hinshaw William | President and CEO | A Award deriv | 2020-09-29 | 2020-10-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Fehlner Paul | SVP and Chief Legal Officer | A Award deriv | 2020-09-16 | 2020-09-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Societe des Produits Nestle S. | 10% Owner | J Other | 2020-09-08 | 2020-09-09 | 4,305,541 | $4.42 | $19.03M | 4,305,541 | SEC↗ |
| Aradhye Shreeram | Director | A Award deriv | 2020-09-01 | 2020-09-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Chakravarthy Manu | SVP & Chief Medical Officer | A Award deriv | 2020-08-01 | 2021-02-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2020-06-05 | 2020-06-08 | 6,800 | — | $0 | 6,800 | SEC↗ |
| Baird William D III | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Behar Gregory | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Hoge Stephen | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Pisano Gary P. | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Rondinone CRISTINA | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2020-05-20 | 2020-05-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Epstein David R | Director | P Buy | 2020-05-18 | 2020-05-20 | 50,000 | $4.75 | $237.5K | 118,103 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2020-05-18 | 2020-05-20 | 380,000 | $4.75 | $1.80M | 1,056,752 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2020-05-18 | 2020-05-20 | 1,900,000 | $4.75 | $9.03M | 2,886,023 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2020-05-18 | 2020-05-20 | 1,520,000 | $4.75 | $7.22M | 4,808,780 | SEC↗ |
| NIMCO US, Inc. | 10% Owner | P Buy | 2020-05-18 | 2020-05-21 | 1,936,842 | $4.75 | $9.20M | 4,305,541 | SEC↗ |
| Epstein David R | Director | P Buy | 2020-02-28 | 2020-03-02 | 2,005 | $3.75 | $7.5K | 68,103 | SEC↗ |
| Epstein David R | Director | P Buy | 2020-02-27 | 2020-03-02 | 12,800 | $3.65 | $46.7K | 66,098 | SEC↗ |
| Chardonnet Laurent | Chief Financial Officer | P Buy | 2020-01-31 | 2020-01-31 | 3,000 | $4.94 | $14.8K | 3,665 | SEC↗ |
| Chardonnet Laurent | Chief Financial Officer | P Buy | 2020-01-27 | 2020-01-28 | 352 | $4.94 | $1.7K | 665 | SEC↗ |
| Chardonnet Laurent | Chief Financial Officer | P Buy | 2020-01-24 | 2020-01-28 | 313 | $4.92 | $1.5K | 313 | SEC↗ |
| Sohn Catherine A. | Director | P Buy | 2020-01-17 | 2020-01-21 | 1,000 | $4.87 | $4.9K | 1,000 | SEC↗ |
| Hinshaw William | President and CEO | A Award deriv | 2020-01-02 | 2020-01-03 | 156,700 | — | $0 | 156,700 | SEC↗ |
| Chardonnet Laurent | Chief Financial Officer | A Award deriv | 2019-12-18 | 2019-12-20 | 72,500 | — | $0 | 72,500 | SEC↗ |
| Chakravarthy Manu | SVP & Chief Medical Officer | A Award deriv | 2019-12-18 | 2019-12-20 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Fehlner Paul | SVP & Chief IP Officer | A Award deriv | 2019-12-18 | 2019-12-20 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Developmnt Offic | A Award deriv | 2019-12-18 | 2019-12-20 | 66,801 | — | $0 | 66,801 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Developmnt Offic | A Award deriv | 2019-12-18 | 2019-12-20 | 54,500 | — | $0 | 54,500 | SEC↗ |
| Tramontin Tony | SVP & Chief Scientific Offic | A Award deriv | 2019-12-18 | 2019-12-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| King-Jones Heidy | General Counsel, SVP Legal | A Award deriv | 2019-12-18 | 2019-12-20 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Mitchener Stephen | SVP & Chief Business Officer | A Award deriv | 2019-12-18 | 2019-12-20 | 43,000 | — | $0 | 43,000 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-11-27 | 2019-12-02 | 1,005 | $3.91 | $3.9K | 53,298 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-11-27 | 2019-12-03 | 1,005 | $3.91 | $3.9K | 53,298 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-11-26 | 2019-12-02 | 14,000 | $3.55 | $49.7K | 52,293 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-11-26 | 2019-12-03 | 14,000 | $3.55 | $49.7K | 52,293 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2019-08-21 | 2019-08-23 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2019-08-21 | 2019-08-23 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2019-08-21 | 2019-08-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-08-02 | 2019-08-05 | 2,849 | $7.04 | $20.1K | 38,293 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-08-01 | 2019-08-05 | 4,092 | $6.98 | $28.6K | 35,444 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-07-17 | 2019-07-18 | 1,000 | $7.55 | $7.5K | 31,352 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-07-10 | 2019-07-10 | 1,322 | $8.07 | $10.7K | 30,352 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-07-09 | 2019-07-10 | 4,200 | $8.24 | $34.6K | 29,030 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-07-08 | 2019-07-10 | 274 | $9.00 | $2.5K | 24,830 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-07-03 | 2019-07-03 | 56 | $8.99 | $503 | 19,056 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-07-02 | 2019-07-03 | 3,500 | $8.77 | $30.7K | 19,000 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-07-01 | 2019-07-03 | 1,000 | $8.74 | $8.7K | 15,500 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-06-28 | 2019-07-01 | 5,400 | $10.04 | $54.2K | 20,000 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-06-27 | 2019-07-01 | 100 | $9.15 | $915 | 14,600 | SEC↗ |
| Epstein David R | Director | P Buy | 2019-06-26 | 2019-06-27 | 14,500 | $9.57 | $138.8K | 14,500 | SEC↗ |
| Hinshaw William | President and CEO | A Award deriv | 2019-05-22 | 2019-05-24 | 60,803 | — | $0 | 60,803 | SEC↗ |
| BERRY DAVID A | Director | A Award deriv | 2019-05-22 | 2019-05-24 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Pisano Gary P. | Director | A Award deriv | 2019-05-22 | 2019-05-24 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Hoge Stephen | Director | A Award deriv | 2019-05-22 | 2019-05-24 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Rondinone CRISTINA | Director | A Award deriv | 2019-05-22 | 2019-05-24 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Baird William D III | Director | A Award deriv | 2019-05-22 | 2019-05-24 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Behar Gregory | Director | A Award deriv | 2019-05-22 | 2019-05-24 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2019-05-22 | 2019-05-24 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 895,255 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 89,525 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 358,102 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 151,643 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 617,914 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 222,506 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 1,005,413 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 1,384,615 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 4,153,847 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 928,074 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion deriv | 2019-05-13 | 2019-05-15 | 386,697 | — | $0 | 0 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 751,691 | — | $0 | 1,430,301 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | P Buy | 2019-05-13 | 2019-05-15 | 500,000 | $20.00 | $10.00M | 986,023 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 486,023 | — | $0 | 486,023 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 48,602 | — | $0 | 676,752 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 194,409 | — | $0 | 3,288,780 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 82,324 | — | $0 | 628,150 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 335,457 | — | $0 | 3,094,371 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 120,795 | — | $0 | 1,761,029 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 2,255,074 | — | $0 | 2,255,074 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 503,840 | — | $0 | 2,758,914 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 209,933 | — | $0 | 1,640,234 | SEC↗ |
| Flagship Ventures Opportunitie | 10% Owner | C Conversion | 2019-05-13 | 2019-05-15 | 545,826 | — | $0 | 545,826 | SEC↗ |